Abstract
As part of an ongoing program to develop potential therapeutic agents for the treatment of the neurodegenerative disease Friedreich׳s ataxia (FRDA), we have prepared a number of lipophilic methylene blue analogues. Some of these compounds significantly increase mitochondrial biogenesis and frataxin levels in cultured Friedreich's ataxia cells [1]. This data article describes the chemical synthesis and full physicochemical characterization of the new analogues.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 1105-1114 |
| Number of pages | 10 |
| Journal | Data in Brief |
| Volume | 20 |
| DOIs | |
| State | Published - Oct 2018 |
ASJC Scopus subject areas
- General